MetLife ETF selling reached a net $45.7 million on October 23, 2026, as larger reductions outweighed purchases even though more funds added shares than sold them.
Key Takeaways
- Nineteen ETFs increased their MetLife holdings, while 10 reduced them.
- AVLV made the largest reported reduction, selling 434,566 shares valued at $42.9 million.
MetLife ETF selling led by AVLV
AVLV cut its MetLife position by 52.26%. The insurer represented 0.18% of the fund’s portfolio after the reduction. SPY and XLF were the next-largest sellers by dollar value.
The figures describe reported changes in ETF holdings of MetLife shares, not confirmed investor withdrawals from the funds. They do not establish why the funds traded.
| Item | Details |
|---|---|
| AVLV | 434,566 MetLife shares sold, valued at $42.9 million |
| SPY | 29,046 shares sold, valued at $2.9 million |
| XLF | 22,040 shares sold, valued at $2.2 million |
Recent trading was mostly negative
The October 23 net sale followed a $1.1 million net purchase on October 22. ETFs had been net sellers on each of the previous three reported days, with sales ranging from $2.8 million to $3.1 million.
Across the five reported days from October 19 through October 23, funds were net sellers on four days and net buyers on one.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
Comments
Be respectful. No spam, impersonation or private credentials. Ordinary posts and comments appear immediately; suspicious links are held for review.
Please wait…